| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
Department of Internal Medicine (R.D.L., R.N.B.), University of New Mexico School of Medicine, Albuquerque, New Mexico
Department of Family and Community Medicine (L.J.R.), University of New Mexico School of Medicine, Albuquerque, New Mexico
Clinical Nutrition Program, Center for Population Health (K.M.K., H.C.L.), University of New Mexico School of Medicine, Albuquerque, New Mexico
Department of Psychiatry (A.L.), University of New Mexico School of Medicine, Albuquerque, New Mexico
Department of Pathology (P.J.G.), University of New Mexico School of Medicine, Albuquerque, New Mexico
Address reprint requests to: Robert D. Lindeman, MD, Department of Internal Medicine, ACC-5, University of New Mexico Health Sciences Center, 2211 Lomas Blvd., N.E., Albuquerque, New Mexico, 87131-5271.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Methods: Equal numbers of male and female Hispanics and NHW were randomly sampled from the Health Care Financing Administration (Medicare) registrant list for Bernalillo County, New Mexico, and asked to volunteer for a paid home interview followed by a paid comprehensive interview/examination covering health and health-related issues. In addition to serum determinations of B12, C and folate, associations were examined between these vitamins and measures of cognitive and affective functions.
Results: Males and Hispanics had lower serum vitamin B12, C and folate concentrations than females and NHW respectively. Participants taking a multivitamin supplement (MVI) had higher serum vitamin concentrations than those not taking MVI. There were significant associations between serum folate concentrations and measures of cognitive function, not seen with B12 or C, nor between any of the vitamins and affective function.
Conclusions: Hispanics, even after adjustments for gender, age, vitamin supplementation, vitamin content of dietary foods, education and household income, had lower serum concentrations of B12, C and folate than NHW. The most significant associations observed were those between serum folate and various measures of cognitive function, even after adjusting for presence of depression.
Key words: vitamin B12 (cobalamin), vitamin C (ascorbic acid), folic acid, Hispanic elderly, cognitive function, depression
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
More recently, evidence has continued to mount showing that the intakes and serum concentrations of certain vitamins, e.g. vitamins B12, folate and C, above those necessary to prevent clinical deficiencies, might importantly influence health status. Supplements of vitamin B12 and folate lower serum homocysteine concentrations, and even minor elevations of serum homocysteine increase the risk of vascular disease [1–8]. Although the body of evidence demonstrating the vascular protective effects of higher B12 and folate intake have been accumulating, this evidence was considered too preliminary for incorporation into the Dietary Reference Intakes for the B vitamins [9]. Similarly, an inverse association has been observed between vitamin C intake and/or serum concentrations and the presence of atherosclerotic vascular disease, notably stroke [10,11].
Poorer cognitive function has been reported in individuals with lower serum concentrations of B12 and/or folate (and higher serum concentrations of homocysteine) [12–16], and vitamin C [17]. Depression has been reported to be the most common neuropsychiatric manifestation of folate deficiency [18–21] and needs to be considered when evaluating cognitive status, as it is well recognized that depression can mimic impaired cognitive function (pseudodementia). Little information is available comparing serum vitamin B12, C and folate in elderly Hispanics and non-Hispanic whites. A recent publication [22] from the National Health and Nutrition Examination Survey (1988–91) reports that serum and red cell folates were significantly lower in younger Mexican Americans compared to non Hispanic whites.
The New Mexico Elder Health Survey (NMEHS) was a study of health and health-related issues in nearly equal numbers of elderly (65 years of age or older) Hispanic and nonHispanic white (NHW) males and females randomly selected from the Health Care Financing Administration (Medicare) rolls of Bernalillo County (Albuquerque), New Mexico [23,24]. One of the objectives of the NMEHS was to compare nutritional status in these two ethnicities, both by obtaining detailed information on dietary intake and supplements and by quantifying serum concentrations of vitamin B12, folate and C. A database also was available on cognitive and affective (depression) functions, which allowed us to make comparisons between vitamin nutritional status and these functions.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Serum Vitamin B12 and Folate
Between May 1993 and March 1994, serum vitamin B12 and folate concentrations were determined on 318 samples using the SimulTRAC Radioassay (RA) kit from Becton-Dickinson (Orangeburg, NY), Cat #262226. Samples collected after March 1994 (n=515) were assayed by the Quantaphase II RA kit from Bio-Rad (Hercules, CA), Cat #191-1041. The introduction of the Quantaphase II RA in 1994 was due to issues associated with the Life Sciences Research Office Report [25], on the assessment of radioassays used to measure serum folate, citing consistently a 30% elevation in folate levels in current radioassays. Because of this factor, a new, but properly standardized procedure, the Quantaphase II RA, was implemented in our laboratory. In comparing folate levels measured by the SimulTRAC RA with the Quantaphase II RA, it was determined that a correction factor (of 0.735) needed to be employed to adjust SimulTRAC RA values to those results obtained using the Quantaphase II RA. In comparing the adjusted results of 80 samples from the SimulTRAC RA (adjusted by a factor of 0.735) with the new Quantaphase II RA, a linear correlation of 0.99 was achieved. In the process of establishing the new B12/folate methodology, it was also noted that a correction factor had to be established for the vitamin B12 levels using the Quantaphase II RA. In comparing 80 samples by both methodologies, the SimulTRAC RA showed B12 levels consistently higher, by 6.4%, when compared to the new Quantaphase II B12 RA. As a result of this comparison, the 318 samples assayed for B12 levels by the SimulTRAC RA were corrected for by a 6.4% factor.
Employing the standardized methodology, B12 and folate concentrations were determined on the remaining 515 serum samples by simultaneously using the 125I/57Co Quantaphase II Radioassay from Bio-Rad Corp (Hercules, CA), Cat #191-1041. The assay’s minimum detectable concentration of B12 is 15 pmol/L (20 pg/mL) and for folate is 0.2 nmol/L (0.1 ng/mL). The normal range, as established by the manufacturer for vitamin B12 is 96 to 567 pmol/L (130–770 pg/mL) and for folate is 0.7–9.5 nmol/L (1.5–20.6 ng/mL) with the coefficient of variation of the inter-assay precision being 4.0% to 5.9% and 3.8% to 5.2%, respectively. The rationales for selection of "cutpoints" of 221 pmol/L (300 pg/mL) to separate participants with normal vs. low and low normal serum vitamin B12 concentrations, and 11 nmol/L (5 ng/mL) for serum folate concentrations is outlined in the discussion.
Vitamin C (ascorbic acid) analysis was performed on serum samples utilizing the procedure described by Garry et al. [26]. The normal range established by this procedure is 28 to 85 µmol/L (0.5 to 1.5 mg/dL) with an assay sensitivity of 14 µmol/L (0.25 mg/dL). The coefficient of variation of the inter-assay precision is 1.5% to 9.6% (n=36 assays).
Neuropsychological Assessment
Cognitive test measures and the functions they were intended to estimate were 1) the Mini-Mental State Exam (MMSE) (orientation, recall, attention, language, and visual graphic ability) [27], 2) WAIS-R Digits Forward (attention and immediate memory) [28], 3) Fuld Object Memory Evaluation (learning and secondary memory) [29], 4) clock drawing (visuoconstruction) [30] and 5) two Color Trail Making Tests (psychomotor speed and cognitive flexibility) [31]. How these measures were used in this population are described in more detail elsewhere [32].
Three indicators of depression were obtained. First, a self report of a past history of depression was available from the interview. Second, a list of all current medications was obtained and coded by a pharmacist so that antidepressants could be identified by a single code number. Third, the 15-question short version of the Yesavage Geriatric Depression Scale (GDS) was administered in both Spanish and English versions [33]. Both the total number of questions answered to indicate depression and percent of participants with greater than six answers indicating depression are reported.
Additional Information
Dietary intakes for the three vitamins were obtained from the Health Habits and History Questionnaire, a food frequency questionnaire, using methods previously described [34]. Information on vitamin supplementation also was obtained. Participants were asked if they had taken any multivitamins (MVI) in the last 12 months (those answering affirmatively were the participants included in the MVI category), how many of the last 12 months had they taken MVI and how many days per week they took them. Of the individuals taking MVI, 85.1% took them daily and 91.5% took them at least every other day; 81.6% had taken them every month for the 12 months prior to the interview. For vitamin C, participants were included in the vitamin supplement category if they took either MVI or vitamin C supplements. Education was quantified both in years of education and whether or not participants had a high school education. Household income was separated into incomes less than $15,000 per year (poverty level) and those $15,000 per year or more.
Statistical Methods
Participants with any component of the necessary database missing were excluded from that analysis. This meant from 751 to 816 participants were included in the four tables. Continuous variables were tested for normality in distribution. A logarithmic transformation was applied to skewed variables, e.g. vitamin intake from food, to normalize distributions before statistical analysis. Group comparisons were conducted using general linear models for continuous variables adjusting for the effects of gender, ethnicity, vitamin supplement usage, age (five-year intervals) education (high school graduate vs. non graduate) and household income (less than $15,000 vs. equal to or greater than $15,000) (Table 2). Also examined was the effect in these models of adjusting for vitamin intake from food. For categorical variables, e.g. serum vitamin concentrations above and below certain cutoff levels (Table 3), and use/nonuse of multivitamin supplements (Table 4), multivariate logistic regression models were fitted for each of the primary outcomes (cognitive and affective tests) adjusting for gender, ethnicity, age (years), education (years), and household income (<$15,000 vs. 
$15,000). Also examined were the effects on each of the cognitive tests of adjusting for each of the three measures of depression. All analyses were done using SAS software [35].
|
|
|
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
Table 3 compares the results of cognitive and affective (depressive) function tests in participants with low and low normal serum concentrations of the three vitamins compared to those with values more clearly within the normal range. Using multivariate logistic regression models to adjust for differences in age, ethnicity, gender and education (years), none of these differences reached levels of statistical significance for B12 or C. For folate, however, participants with low (and low normal) serum concentrations were associated with lower cognitive performance scores when compared to participants with normal folate levels. Lower scores were associated with low serum folates in the Mini Mental Status Exam, the Digits Forward, the Fuld Object Memory test, (number retrieved, number of names, number recalled) and one of the two Color Trails tests, but not in the Clock Face test. Using lower cutoff points to define a vitamin deficiency state, i.e. 200 pg/mL for B12 and 3 ng/mL for folate, did not change the findings. Those individuals with low normal serum B12 concentrations did not have different mean corpuscular volumes compared to those with normal B12 concentrations (mean±SD 90.6±5.5 vs. 90.5±5.2).
Because others [18–21] have found an association between serum folate concentrations and evidence of depression and because depression can lower cognitive scores (pseudodementia), depression was entered into additional multivariate logistic regression models as an additional variable examining cognitive outcomes. Several methods were available to determine the presence or absence of depression. The 15 question Yesavage Geriatric Depression Scale (GDS) with a score >6 consistent with depression was used as the primary method, but information also was utilized on self report of a past medical history of depression and on current use of prescription antidepressants. Of 861 participants who provided this information, 96 (11.1%) had a GDS consistent with depression (>6); only 16 (16.7%) were currently on antidepressants. Another 28 of 765 participants (3.7%), not clinically depressed by the GDS, also currently were on antidepressants. When one examined the 194 participants with a past history of depression, only 12.9% were currently on antidepressants. There was a highly significant correlation between the Mini Mental Status Exam and each of these three measures of depression (p<.001).
Adding each of the three measures of depression as a variable into the multivariate logistic regression models, serum folate concentrations continued to show significant associations with measures of cognitive function. Using the dichotomized level of GDS >6 vs. 6 in the model, significant associations still were found between serum folate concentrations and the MMSE and number of names (p<.01), and Fuld (total recalled) and color trails #2 tests (p.05). Using a history of depression as the variable instead of the GDS gave very similar results, except the last two tests of cognitive function were now only marginally significant (p=.06).
Table 4 compares those participants on MVI with those not on MVI. No significant association of cognitive or affective function with MVI use was observed after adjusting for differences in age, ethnicity, gender and years of education. The participants taking MVI had more education than those not taking MVI, even after adjusting for ethnic differences where more NHW took MVI than Hispanics.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Other observations, e.g., that males had significantly lower serum concentrations compared to females, that daily vitamin supplements increased serum vitamin concentrations, that a direct association existed between food vitamin intake and serum vitamin concentrations (exclusive of vitamin supplements) and that participants with less education and incomes below the poverty level had lower serum vitamin concentrations were more predictable based on previous publications [37–41]. While not all participants in the multivitamin supplement category took a multivitamin daily for all 12 months prior to the testing done, such a high percentage did that this should not affect the ability to find significant differences between the groups receiving multivitamin supplements and those not receiving them, if the effects on cognition and mood really existed.
Although ranges of "normal" values are generally established in clinical laboratories, the rationales for these levels are not always clear. With no clear, independent, objective markers for clinical B12, C and folate deficiencies, the distinctions between true early biochemical deficiencies of these vitamins and the lower limits of normal become somewhat arbitrary. Florid presentations of vitamin deficiencies, e.g., the megaloblastic anemia and neurologic dysfunction seen with pernicious anemia (B12 deficiency), are becoming rare. More often marginal or mild deficiencies are detected by screening serum or red cell concentrations of the vitamins or by finding evidence of accumulation of a metabolite; for example, an increase in serum methylmalonic acid (MMA) can be indicative of a B12 deficiency, or an increase in serum homocysteine can be related to a deficiency of either folate or B12. Some of these metabolites may be responsible for subtle pathophysiologic changes, such as the excessive cardiovascular mortality now well documented to result from an increase in serum homocysteine concentrations [1–8]. It therefore becomes important to identify these early or marginal deficiencies and to identify populations that may be at increased risk.
An extensive literature exists on the neuropsychiatric manifestations of cobalamin (B12) deficiency that often are present without the macrocytic anemia seen with classic pernicious anemia due to a deficiency of intrinsic factor. This has been comprehensively reviewed recently by Van Goor, et al. [18]. Malabsorption of cobalamin due to intrinsic factor deficiency can be measured by the Schilling test. In elderly individuals, low serum cobalamins often are found with normal Schilling tests and appear to be the result of protein-bound cobalamin malabsorption. Here the release of cobalamin from its dietary protein-bound state is impaired, often but not necessarily due to achlorhydria [42]. In recognition of the fact that 20 to 30 percent of elderly persons may malabsorb food-bound B12, it has been recommended that those older than 50 years meet the Recommended Dietary Allowance (RDA) for B12 (2.4 micrograms/day) from supplements and/or from foods fortified with B12 (such as breakfast cereals) [9].
Memory deficits and slowing of mental processes are the most commonly reported cognitive disturbances in cobalamin deficiency, but organic mental changes resulting in paranoia, hallucinations and delirium also have been described [18]. Such patients with an organic psychosis and cognitive dysfunction have been reported to show a complete recovery with cobalamin therapy [43–45].
Despite the widespread use of the serum B12 concentrations in epidemiologic studies, and as a screening procedure, it has been recognized that there are formidable problems of sensitivity and specificity with this test [46,47]. A low serum B12 does not necessarily indicate a deficiency state exists, and a "normal" B12 does not rule out a deficiency. Metz, et al. [48] showed that 90% of older patients with serum B12 <150 pmol/L showed evidence of tissue B12 deficiency. They felt the deficiency became manifest at relatively higher levels of serum B12 in older patients, possibly because of lower levels of holotranscobalamin II in older patients. Most cobalamin is bound to transcobalamin I, which has little functional significance; the 10% to 20% that is bound to transcobalamin II is the functionally active component, and this tends to be low in the elderly. Since there are no good commercial techniques to quantify transcobalamin II available, the best alternative to identify B12-deficient individuals appears to be to measure the serum concentrations of MMA and homocysteine and the response to therapy with B12. Stabler [47], in reviewing a study on a cohort of geriatric outpatients [49], felt the conventional practice of setting the lower limits of normal for B12 at 200 pg/mL (147 pmol/L) missed approximately 50% of B12-deficient individuals. Many subjects with "low normal" levels (between 200 and 300 pg/mL) had metabolites (MMA and/or homocysteine) elevated more than two standard deviations above the mean which subsequently responded to treatment with B12. Bernard et al. [19], on the other hand, reported that elderly veterans with low B12 levels, as defined by a serum B12 level <200 pg/mL, had evidence of cognitive impairment compared to those above this level. When a broader definition of B12 deficiency was used, i.e. <300 pg/mL and elevation of MMA and/or homocysteine, no significant differences were observed. We therefore used both the 200 and 300 pg/mL cutpoints to dichotomize our findings for analysis, but have reported only the latter. Using the 300 pg/mL cutpoint, 21% of our participants had low serum B12 concentrations. Neither of these cutpoints showed any significant association between low B12 concentrations and cognitive or affective (mood) function. Some of this failure may be related to the inability of the serum B12 concentration to adequately identify B12 deficient participants.
Low serum folate concentrations also have been associated with poorer function on neuropsychological assessment [16,17,20,50]. Goodwin et al. [50] reported lower test scores on a non-verbal test of abstract thinking ability and on a memory test for healthy elderly with low folate levels compared to those with normal levels. In a previous report on 137 elderly (age 66 to 90 years), well educated, well nourished community residents in the New Mexico Aging Process Study free of cognitive impairment, we reported no differences in tests of memory and visual perception between those individuals taking vitamin supplements and those not taking them [20]. However, on more complex measures of performance involving visuospatial skills, abstraction and non-verbal memory, those individuals taking supplements, including B12, C and folate, generally scored significantly higher than those not taking supplements. Similarly, Riggs et al. [16] reported poorer spatial copying skills in those with low folates. The Framingham study [51], in their analysis of "low and low normal" serum folate concentrations, used a level less than 5 ng/mL (11.1 nmol/L), in contrast to the more traditional level distinguishing a deficiency as that below 3 ng/mL. Using the former cutpoint, 18% of our participants had low serum folate concentrations. Here we saw lower scores on a number of cognitive tests involving learning, memory and psychomotor speed in participants with low or low normal serum folate concentrations compared to those with normal serum concentrations.
Although we were unable to show any association between serum folate levels and the presence or absence of depression, an important consideration is to diagnose depression accurately, as it is well recognized that impaired cognitive status can be a result of depression (pseudodementia). In 1962, Herbert [18] reported an association between folate deficiency and depressive symptoms, experiencing himself insomnia, irritability, fatigue and forgetfulness after four months on a folate-deficient diet. Albert and Fava [19] review the literature showing the relationship between folate and neuropsychiatric disorders inferred from clinical observation and the current understanding of the role of folate in critical brain metabolic pathways. Depressive symptoms have been reported to be the most common neuropsychiatric manifestations of folate deficiency. Conversely, low serum and/or red cell folate levels have been detected in 15% to 38% of adults diagnosed with depressive disorders [19–21] and low folate levels have been linked to poorer antidepressant response to selective serotonin reuptake inhibitors [19].
Perrig et al. [21] recently reviewed the effects of the antioxidant vitamins, including vitamin C, on cognitive function. Although there had been previous correlational studies in healthy older people suggesting that low serum vitamin C might be associated with poorer mental function [50], there was no clear effect of the antioxidant vitamins on cognitive performance, especially memory, in these previous studies. Perrig et al. [21], however, did find a positive correlation between plasma ascorbic acid concentrations and memory performance in people aged 65 and older. Although none of the cognitive tests in our study showed such a positive correlation, two tests of memory came close (p<0.1).
Within the next few years, ongoing and planned randomized trials should help to resolve many of the uncertainties described above. At present, in recognition of absorption problems, the elderly are recommended to obtain the RDA for vitamin B12 from supplements or fortified foods. However, the combined evidence does not support the routine use of higher supplement doses of vitamin B12, or of folate or vitamin C supplements to protect against cognitive loss or mood disorders (depression). Individual choices and public policy decisions should await the results of large trials, which will provide more information on the efficacy and safety of these vitamins.
|
ACKNOWLEDGMENTS |
|---|
Received April 1, 1999. Accepted September 1, 1999.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
This article has been cited by other articles:
|
|
 |
|
  J.-M. Kim, R. Stewart, S.-W. Kim, S.-J. Yang, I.-S. Shin, and J.-S. Yoon Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression The British Journal of Psychiatry, April 1, 2008; 192(4): 268 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Selhub, M. S. Morris, and P. F. Jacques In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations PNAS, December 11, 2007; 104(50): 19995 - 20000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. de Lau, H. Refsum, A D. Smith, C. Johnston, and M. M. Breteler Plasma folate concentration and cognitive performance: Rotterdam Scan Study Am. J. Clinical Nutrition, September 1, 2007; 86(3): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gilbody, T. Lightfoot, and T. Sheldon Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity J. Epidemiol. Community Health, July 1, 2007; 61(7): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hao, J. Ma, J. Zhu, M. J. Stampfer, Y. Tian, W. C. Willett, and Z. Li Vitamin B-12 Deficiency Is Prevalent in 35- to 64-Year-Old Chinese Adults J. Nutr., May 1, 2007; 137(5): 1278 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Luchsinger, M.-X. Tang, J. Miller, R. Green, and R. Mayeux Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly Arch Neurol, January 1, 2007; 64(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Feng, T.-P. Ng, L. Chuah, M. Niti, and E.-H. Kua Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1506 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tettamanti, M. T. Garri, A. Nobili, E. Riva, and U. Lucca Low Folate and the Risk of Cognitive and Functional Deficits in the Very Old: The Monzino 80-plus Study J. Am. Coll. Nutr., December 1, 2006; 25(6): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. McMahon, T. J. Green, C. M. Skeaff, R. G. Knight, J. I. Mann, and S. M. Williams A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med., June 29, 2006; 354(26): 2764 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Shelley Integrative Medicine Research in New Mexico: Lessons From the Published Literature Complementary Health Practice Review, April 1, 2006; 11(2): 107 - 119. [Abstract] [PDF]
|
|
|
|
|
|
M. I Ramos, L. H Allen, D. M Mungas, W. J Jagust, M. N Haan, R. Green, and J. W Miller Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1346 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Elias, L. M. Sullivan, R. B. D'Agostino, P. K. Elias, P. F. Jacques, J. Selhub, S. Seshadri, R. Au, A. Beiser, and P. A. Wolf Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important Am. J. Epidemiol., October 1, 2005; 162(7): 644 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Lindeman, S. J. Wayne, R. N. Baumgartner, and P. J. Garry Cognitive Function in Drinkers Compared to Abstainers in The New Mexico Elder Health Survey J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, L. E. Hebert, P. A. Scherr, and J. A. Schneider Dietary Folate and Vitamin B12 Intake and Cognitive Decline Among Community-Dwelling Older Persons Arch Neurol, April 1, 2005; 62(4): 641 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wouters-Wesseling, L. W. Wagenaar, M. Rozendaal, J. B. Deijen, L. C. de Groot, J. G. Bindels, and W. A. van Staveren Effect of an Enriched Drink on Cognitive Function in Frail Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2005; 60(2): 265 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Scott, K. L. Tucker, A. Bhadelia, B. Benjamin, S. Patz, R. Bhadelia, E. Liebson, L. L. Price, J. Griffith, I. Rosenberg, et al. Homocysteine and B Vitamins Relate to Brain Volume and White-Matter Changes in Geriatric Patients With Psychiatric Disorders Am J Geriatr Psychiatry, December 1, 2004; 12(6): 631 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I Ramos, L. H Allen, M. N Haan, R. Green, and J. W Miller Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1024 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tolmunen, S. Voutilainen, J. Hintikka, T. Rissanen, A. Tanskanen, H. Viinamaki, G. A. Kaplan, and J. T. Salonen Dietary Folate and Depressive Symptoms Are Associated in Middle-Aged Finnish Men J. Nutr., October 1, 2003; 133(10): 3233 - 3236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lee, I. Kawachi, L. F. Berkman, and F. Grodstein Education, Other Socioeconomic Indicators, and Cognitive Function Am. J. Epidemiol., April 15, 2003; 157(8): 712 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Grodstein, J. Chen, and W. C Willett High-dose antioxidant supplements and cognitive function in community-dwelling elderly women Am. J. Clinical Nutrition, April 1, 2003; 77(4): 975 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. MARSHALL, J. J. WARREN, J. S. HAND, X.-J. XIE, and P. J. STUMBO Oral health, nutrient intake and dietary quality in the very old J Am Dent Assoc, October 1, 2002; 133(10): 1369 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, and R. S. Wilson Vitamin E and Cognitive Decline in Older Persons Arch Neurol, July 1, 2002; 59(7): 1125 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
